€5.35
2.73%
Xetra, Sep 21, 05:35 pm CEST. Closed.
ISIN
DE0006595101
Symbol
MED
Index

MediClin Stock price

€5.35
+0.30 5.94% 1M
+1.97 58.28% 6M
+1.65 44.59% YTD
+2.37 79.53% 1Y
+2.67 99.63% 3Y
+1.51 39.32% 5Y
-0.35 6.16% 10Y
+1.15 27.50% 20Y
Xetra, Closing price Mon, Sep 21 2026
-0.15 2.73%
ISIN
DE0006595101
Symbol
MED
Index

Is MediClin a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,133 stocks worldwide.

Key metrics

Basic
Market capitalization
€270.8m
Enterprise Value
€494.0m
Net debt
€223.2m
Cash
€159.1m
Shares outstanding
47.5m
Valuation (TTM | estimate)
P/E
8.9
P/S
0.3 | 0.3
EV/Sales
0.6 | 0.6
EV/FCF
9.5
P/B
1.0
Dividends
DPS
€0.04
Yield 1Y | 5Y
0.7% | 0.5%
Growth 1Y | 5Y
0.0% | -
Payout 1Y | 3Y
7.4% | 9.6%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€816.2m | €813.7m
EBITDA
€120.8m
EBIT
€59.6m
Net Income
€29.1m
Free Cash Flow
€52.0m
Growth (TTM | estimate)
Revenue
4.4% | 1.2%
EBITDA
4.5%
EBIT
-6.7%
Net Income
-14.3%
Free Cash Flow
19.9%
Margin
Gross
84.9%
EBITDA
14.8%
EBIT
7.3%
Net
3.6%
Free Cash Flow
6.4%
Financial Health
Equity Ratio
29.6%
Return on Equity
10.2%
ROCE
8.8%
ROIC
7.9%
Debt/Equity
1.5
More
EPS
€0.6
FCF per Share
€1.1
Short interest
-
Employees
7k
Rev per Employee
€110.0k

MediClin Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a MediClin forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a MediClin forecast:

Buy
83%
Hold
17%

Financial data from MediClin

Jun '26
+/-
%
816 816
4% 4%
100%
- Direct Costs 123 123
2% 2%
15%
693 693
6% 6%
85%
- Selling and Administrative Expenses 496 496
4% 4%
61%
- Research and Development Expense - -
-
-
121 121
5% 5%
15%
- Depreciation and Amortization 61 61
18% 18%
7%
EBIT (Operating Income) EBIT 60 60
7% 7%
7%
Net Profit 29 29
14% 14%
4%

In millions EUR.

Don't miss a Thing! We will send you all news about MediClin directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

MediClin AG engages in the operation of hospitals, rehabilitation clinics, care homes and medical centers. It operates through the following segments: Post-Acute, Acute and Other Activities. The Post-Acute segment offers subsequent nursing and curative treatment services. The Acute segment focuses on neurology and neurological early rehabilitation, psychosomatic medicine, psychiatry, orthopedic and internal medicine. The Other Activities segment refers to nursing care and service business area including software support, controlling activities, quality assurance and other central services. The company was founded on September 12, 1996 and is headquartered in Offenburg, Germany.

Head office Germany
CEO Dr. Ramming
Employees 7,416
Founded 1996
Website www.mediclin.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today